Definition of yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A

Page Options

	Quick Links


	Director's Corner Updates from the Director Dictionary of Cancer Terms Cancer-related terms NCI Drug Dictionary Definitions, names, and links Funding Opportunities Research and training NCI Publications Order/download free booklets Advisory Boards and Groups Information, meetings, reports Science Serving People Learn more about NCI Español Información en español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

Quit Smoking Today

	NCI Highlights


	Report to Nation Finds Declines in Cancer Incidence, Death Rates High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E The Nation's Investment in Cancer Research FY 2009 Past Highlights

Search for

Starts with

Contains

In English En español

yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A (IH-tree-um … MAH-noh-KLOH-nul AN-tih-BAH-dee …)

A substance being studied in the treatment of some types of cancer. M5A is a monoclonal antibody that binds to a protein called CEA on the surface of some tumor cells. It is linked to a radioisotope called yttrium Y 90, which may help kill the cancer cells. Yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A is a type of radioimmunoconjugate and a type of radiopharmaceutical.

Previous Definitions:	YM598, yoga, yohimbe, yttrium, yttrium Y 90
Next Definitions:	yttrium Y 90 DOTA monoclonal antibody HuPAM4, yttrium Y 90 DOTA monoclonal antibody HuAFP31, yttrium Y 90 DOTA-biotin, yttrium Y 90 DOTA-tyr3-octreotide, yttrium Y 90 edotreotide